Skip to content

EU · EudraLex Vol.4

EU GMP Annex 1 8.11

8. Production and Specific Technologies › Aseptic preparation and processing

Section text

For sterile products where the final formulation cannot be filtered, the following should be considered:

i. All product and component contact equipment should be sterilised prior to use.

ii. All raw materials or intermediates should be sterilised and aseptically added.

iii. Bulk solutions or intermediates should be sterilised.

Source: European Commission, DG SANTE · © European Union. Reuse is authorised provided the source is acknowledged (Commission Decision 2011/833/EU on the reuse of Commission documents). · retrieved 2026-11-15

Weekly Newsletter

Get new findings like these every Monday

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.